Remember meForgot password?
    Log in with Twitter

zmapp News

ZMapp drug shows further Ebola promise

The results of a new clinical trial for Ebola Virus Disease have been published. The trial results indicate the medication was well-tolerated by patients and shows promise for tackling the virus.

Norway’s Ebola victim to get world’s last dose of possible cure

A Norwegian health worker from Sierra Leone, who was diagnosed with Ebola Monday and flown to Oslo Tuesday, will be given the world’s last remaining dose of ZMAPP, a drug being tested as a possible cure for the deadly virus.

Op-Ed: Ebola drugs are a 'long way off' from large-scale production

The announcement that World Health Organization (WHO) consultants have agreed that experimental Ebola drugs can be used to tackle the African outbreak made headlines. However drug companies cannot readily produce the medications in large supplies.

Missionary with Ebola repatriated to Spain has died

Madrid - Miguel Pajares, 75, was recently brought home to Spain from Liberia, suffering from the deadly Ebola virus. Despite being treated with the experimental drug ZMapp, he has reportedly passed away from the disease on Tuesday morning.

Second experimental Ebola drug gains approval

Washington - Following the use of the experimental Ebola treatment drug ZMapp on two U.S. aid workers in Liberia, the U.S. FDA has partially approved a second medication. The drug, TKM-Ebola, has been approved from the next phase of clinical trials.

Search Digital Journal Archives

Set up a news alert for


zmapp Image

Latest News
Top News